Advent Therapeutics, Inc.
PrivateLast Round
Grant
Jul 18, 2023
Total Funding Raised
$6.48M
Company Overview
Advent Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Pennsylvania. Its latest recorded funding round was a Grant round in July 2023.
Advent Therapeutics, Inc. is a biotechnology company that develops therapies for neonatal, pediatric, and orphan drug niche markets to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Advent Therapeutics, Inc. Comparables
Compare Advent Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AyuVis Research | 90% | |
| Airway Therapeutics | 84% | |
| orphanix GmbH | 81% |
For institutional investors. Book with your work email.
Advent Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 18, 2023 | ||||
| Seed | Jan 31, 2017 |
For institutional investors. Book with your work email.
Advent Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Seed |
| National Heart, Lung, and Blood Institute | Grant |
| National Center for Advancing Translational Sciences | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2023
$3M grant from NIH, NHLBI, and NCATS.
- Jan 31, 2017
Secured seed funding from Benjamin Franklin Technology Partners.
For institutional investors. Book with your work email.
Advent Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Advent Therapeutics, Inc.'s valuation, stock price, and market status.
Is Advent Therapeutics, Inc. a public or private company?
Advent Therapeutics, Inc. is a private company.
What is the current stock price of Advent Therapeutics, Inc.?
Advent Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Advent Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Advent Therapeutics, Inc. worth (valuation)?
Valuation information for Advent Therapeutics, Inc. is not publicly available.
Can I buy Advent Therapeutics, Inc. stock?
Advent Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Advent Therapeutics, Inc.'s last funding round?
Advent Therapeutics, Inc.'s most recent funding round was Grant on July 18, 2023.
Who are the main investors in Advent Therapeutics, Inc.?
Key investors in Advent Therapeutics, Inc. include Benjamin Franklin Technology Partners, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences, National Institutes of Health (NIH).
Will Advent Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Advent Therapeutics, Inc..
How can I track Advent Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Advent Therapeutics, Inc.'s shares on secondary markets.